SERA
Sera Prognostics, Inc.
NASDAQ · USHealthcareMedical - Diagnostics & Research
$2.03-0.98%
Price as of Jul 20, 2026
SERA profitability
Sera Prognostics, Inc. profitability
Margins, returns on capital and operating-efficiency metrics from the latest trailing period.
Margins
- Gross margin
- -191.2%
- EBITDA margin
- —
- EBIT margin
- —
- Net margin
- —
- Free cash flow margin
- —
Returns
- Return on equity
- -47.5%
- Return on assets
- -34.4%
- Return on invested capital
- -52.2%
- Asset turnover
- 0.00x
Cash efficiency
- Cash from operations
- -$26.8M
- Cash per share
- $1.21
Latest available reported and market-derived figures. A dash means the source dataset does not currently cover that metric; it does not imply a zero value.